We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Calorie Reduction Extends Health Span and Lowers Levels of Inflammatory Protein
News

Calorie Reduction Extends Health Span and Lowers Levels of Inflammatory Protein

Calorie Reduction Extends Health Span and Lowers Levels of Inflammatory Protein
News

Calorie Reduction Extends Health Span and Lowers Levels of Inflammatory Protein

Credit: CDC/ Unsplash
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Calorie Reduction Extends Health Span and Lowers Levels of Inflammatory Protein "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Reduced calorie intake has been shown to improve health and lifespan in laboratory animals, and recent research shows these benefits may extend to humans as well.


In a new study, Yale researchers show that moderate calorie restriction in people reduces the production of a protein called SPARC, which then reins in harmful inflammation and improves health in the aged. It could be a target for extending human health span, they report Aug. 12 in the journal Immunity.


The study, led by Vishwa Deep Dixit, the Waldemar Von Zedtwitz Professor of Pathology, professor of immunobiology and comparative medicine, and director of the Yale Center for Research on Aging, follows a study published earlier this year that identified key health benefits of moderate calorie reduction in humans.


In the new study, Dixit and his co-authors further analyzed data from a clinical trial funded by the National Institutes of Health. In the trial, known as Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE), some participants reduced their calorie intake by 14% for two years, while others ate as usual; researchers then tracked the long-term health effects.


Specifically, Dixit and his colleagues analyzed trial data to identify molecules that are responsible for the positive effects of calorie reduction and could be targets for therapeutic treatment.


Looking for genetic changes in participants’ fat tissue after one and two years, they found that those who consumed fewer calories had reduced amounts of a protein called SPARC — or secreted protein acidic and rich in cysteine — which has been linked to obesity, diabetes, and inflammation.


Because inflammation plays such a big role in age-related decline, we wanted to better understand whether a pro-longevity intervention like calorie restriction works through SPARC in controlling inflammation and immune responses,” said Dixit. So, to dig deeper into SPARC’s contributions to inflammation they studied what effects the protein had on mouse immune cells and mouse health.


The researchers found that SPARC triggered inflammation by converting anti-inflammatory immune cells called macrophages into a pro-inflammatory state. However, lowering SPARC production by fat cells in mice reduced inflammation, improved metabolism, and extended their health span as they aged.


The findings could lead to preventions for age-related decline, said Dixit.


We now have a better understanding of how SPARC affects inflammation and health span by acting on macrophages,” he added. “And it may be a useful target for inducing the health benefits of calorie restriction without having to actually alter calorie intake.”


Reference: Ryu S, Sidorov S, Ravussin E, et al. The matricellular protein SPARC induces inflammatory interferon-response in macrophages during aging. Immunity. 2022;0(0). doi: 10.1016/j.immuni.2022.07.007


This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

 
Advertisement